Age for Initiating Prednisolone in Children

Condition-Specific Age Recommendations

The American Academy of Neurology recommends that glucocorticoid initiation is NOT recommended for children under 2 years of age who are still gaining motor skills, with typical age for initiating prednisolone being 4-8 years for Duchenne Muscular Dystrophy 1, 2
For children with Duchenne Muscular Dystrophy, starting at age 6 years (±2 years) is the standard approach, with dosing at 0.75 mg/kg/day 1
The American Academy of Pediatrics suggests that for children under 2 years showing improvement, glucocorticoid therapy should be deferred for Duchenne Muscular Dystrophy 1, 2
The International Study of Kidney Diseases in Children recommends that for children under 12 years presenting with new nephrotic syndrome without syndromic features, glucocorticoids should be initiated without requiring a kidney biopsy first 3
The American Academy of Pediatrics recommends standard dosing of 60 mg/m²/day or 2 mg/kg/day (maximum 60 mg/day) for 4-6 weeks for nephrotic syndrome 4
The American Thoracic Society suggests that prednisolone at 1-2 mg/kg/day (maximum 60 mg/day) can be used for acute asthma exacerbations in children 5
The American Academy of Pediatrics recommends that corticosteroids (prednisolone or prednisone at 2-3 mg per kg per day) are an alternative therapy when propranolol cannot be used for infantile hemangiomas, with no specific minimum age restriction mentioned 6

The American Academy of Pediatrics recommends that all pediatric patients on prednisolone require close monitoring regardless of age, with specific attention to growth velocity as the most sensitive indicator of systemic corticosteroid exposure, including monitoring of blood pressure at each visit, using age and height-specific percentiles 1
The American Academy of Neurology suggests that essential monitoring includes annual screening for cataracts, annual DEXA scans and vitamin D monitoring for long-term use, and urine glucose screening and blood glucose if positive 1

The American Academy of Pediatrics recommends that complete immunization schedule should be completed before starting steroids, including varicella vaccination, for infants and very young children 1, 2
The American Academy of Pediatrics suggests that for all pediatric ages, titrate to the lowest effective dose to minimize growth effects, and for significantly overweight children, dose based on ideal body weight to avoid excessive steroid exposure 4, 7
The American Thoracic Society recommends that courses under 10 days do not require tapering, and never stop glucocorticoids abruptly—ensure gradual taper for prolonged courses 1, 5

The American Academy of Pediatrics recommends that prednisolone should NOT be used for non-specific cough in children without clear asthma features, and should NOT be initiated in children under 2 years with Duchenne muscular dystrophy who are still making motor progress 1, 2, 5
The American Thoracic Society suggests that prednisolone should NOT be used for virus-induced wheezing in children under 5 years presenting to hospital, and should NOT delay steroid administration in true asthma exacerbations, as underuse is associated with increased mortality 5

Prednisolone may be initiated at any pediatric age for acute asthma exacerbations at a dose of 1–2 mg/kg per day (maximum 60 mg/day) [8][9].

Children 0–4 years: a short‑course burst of 1–2 mg/kg per day (maximum 30 mg/day) for 3–10 days 8.
Children 5–11 years: a short‑course burst of 1–2 mg/kg per day (maximum 60 mg/day) for 3–10 days [8][9].

Prednisolone at 2–3 mg/kg per day given as a single morning dose can be used as an alternative to propranolol for infantile hemangiomas when propranolol is contraindicated, with no defined minimum age limit. 12
Initiating prednisolone therapy during the proliferative phase of the hemangioma yields the greatest clinical response, and treatment typically extends for several months. 12

In children younger than 12 years with newly diagnosed nephrotic syndrome, glucocorticoid therapy should be started promptly without awaiting a renal biopsy; the recommended regimen is 60 mg/m² per day (or 2 mg/kg per day) up to a maximum of 60 mg daily for a duration of 4–6 weeks. 13
The primary target population for this regimen is children older than 1 year, because infants under 1 year are more likely to have a genetic etiology that requires alternative management strategies. 13